Biotricity, Inc.
BTCY
$0.6332
$0.00280.44%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.12% | 14.31% | 14.09% | 13.55% | 15.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.12% | 14.31% | 14.09% | 13.55% | 15.47% |
| Cost of Revenue | -8.64% | -12.98% | -15.00% | -21.21% | -23.01% |
| Gross Profit | 28.57% | 26.43% | 29.40% | 35.17% | 43.52% |
| SG&A Expenses | -28.65% | -25.70% | -14.59% | -18.12% | -15.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.94% | -22.27% | -14.19% | -19.81% | -18.02% |
| Operating Income | 86.23% | 72.26% | 49.79% | 51.24% | 44.06% |
| Income Before Tax | 62.45% | 40.25% | 26.85% | 24.83% | 16.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 62.45% | 40.25% | 26.85% | 24.83% | 16.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 62.45% | 40.25% | 26.85% | 24.83% | 16.88% |
| EBIT | 86.23% | 72.26% | 49.79% | 51.24% | 44.06% |
| EBITDA | 86.30% | 72.31% | 49.83% | 51.27% | 44.08% |
| EPS Basic | 86.57% | 58.09% | 37.97% | 29.97% | 16.55% |
| Normalized Basic EPS | 84.46% | 72.74% | 52.53% | 43.63% | 29.39% |
| EPS Diluted | 86.56% | 58.08% | 37.97% | 29.97% | 16.55% |
| Normalized Diluted EPS | 84.46% | 72.74% | 52.53% | 43.63% | 29.39% |
| Average Basic Shares Outstanding | 140.10% | 142.58% | 99.48% | 57.51% | 18.86% |
| Average Diluted Shares Outstanding | 140.10% | 142.58% | 99.48% | 57.51% | 18.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.66% | -1.80% | -0.37% | 0.87% | 0.93% |